{"abstract": "The newest data showed that the Xience V stent outperformed the market leader in preventing coronary arteries from reclogging over a two-year period in more than 600 patients.", "web_url": "https://www.nytimes.com/2007/11/27/business/27cnd-stent.html", "snippet": "The newest data showed that the Xience V stent outperformed the market leader in preventing coronary arteries from reclogging over a two-year period in more than 600 patients.", "lead_paragraph": "The data continue to be favorable for Abbott Laboratories\u2019 new drug-coated heart stent, Xience V, a device for which the company hopes to win federal approval. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Postive Data for Abbott\u2019s Proposed Heart Stent", "kicker": null, "content_kicker": null, "print_headline": "Postive Data for Abbott\u2019s Proposed Heart Stent", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Heart", "rank": 1, "major": "N"}, {"name": "organizations", "value": "ABBOTT LABORATORIES INC", "rank": 2, "major": "N"}, {"name": "subject", "value": "Stents (Medical Devices)", "rank": 3, "major": "N"}], "pub_date": "2007-11-27T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Barnaby J. Feder", "person": [{"firstname": "Barnaby", "middlename": "J.", "lastname": "Feder", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/0acc88fa-6cba-5aba-b365-b947f57ec60d", "word_count": 567, "uri": "nyt://article/0acc88fa-6cba-5aba-b365-b947f57ec60d"}